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EVIDENCE BASED MEDICINE
My patient has carotid stenosis. Should he get stenting or endarterectomy?
Quratulain Shaikh, Ayeesha Kamran Kamal

Why is the study important?

carotid endarterectomy (2.0% and 2.4%, respectively; p<0.85).

Extracranial atherosclorerotic disease is an important cause of
stroke. Guidelines for practice are still sparse as to whether
these patients will benefit more from angioplasty or
endarterectomy and trials have shown conflicting results. The
primary aim of the Carotid Revascularization Endarterectomy
vs. Stenting Trial (CREST) was to compare the outcomes of
carotid-artery stenting with those of carotid endarterectomy
among patients with symptomatic or asymptomatic
extracranial carotid stenosis.

What were the conclusions?

Who were the participants? What was the
intervention?
Patients were recruited from 108 centres in the United States
and 9 in Canada. Centres assigned patients with symptomatic
or asymptomatic carotid stenosis to undergo carotid-artery
stenting or carotid endarterectomy. The primary composite
end point was stroke, myocardial infarction, or death from any
cause during the periprocedural period or any ipsilateral
stroke within 4 years after randomization. 2502 patients were
enrolled and followed up for a median of 2.5 years. 1271
patients were in the carotid artery stenting arm and 1251 in
the carotid endarterectomy arm.

What were the findings?
There was no significant difference in the estimated 4-year
rates of the primary end point between carotid-artery stenting
and carotid endarterectomy (7.2% and 6.8%, respectively;
hazard ratio for stenting, 1.11; 95% confidence interval [CI],
0.81 to 1.51; p <0.51) .Of the end-point events, 13 strokes were
fatal (7 in the stenting group and 6 in the endarterectomy
group), and 1 myocardial infarction was fatal (in the
endarterectomy group). An interaction between age and
treatment efficacy was detected (p<0.02) with a crossover at
an age of approximately 70 years. Carotid-artery stenting
tended to show greater efficacy at younger ages, and carotid
endarterectomy at older ages. The incidence of ipsilateral
stroke was similarly low with carotid-artery stenting and with

CREST results indicate that carotid-artery stenting and carotid
endarterectomy were associated with similar rates of the
primary composite outcome which is periprocedural stroke,
myocardial infarction, or death and subsequent ipsilateral
stroke among men and women with either symptomatic or
asymptomatic carotid stenosis. However, the incidence of
periprocedural stroke was lower in the endarterectomy group
than in the stenting group, whereas the incidence of
periprocedural myocardial infarction was lower in the stenting
group. The selection of patients for either carotidartery
stenting or carotid endarterectomy may require attention to
age, with younger patients having a slightly better outcome
with carotid artery stenting and older patients having a better
outcome with carotid endarterectomy.

How can this study affect our clinical practice?
Although carotid disease is not a frequent cause of stroke in
Pakistanis, it is important to appreciate that the intervention
of angioplasty that appears relatively benign may be
associated with more periprocedural stroke than CEA in the
best of international centres. As we develop more
sophisticated interventional centres in Pakistan, strict internal
audit of both our CEA and CAS will guide the right
intervention for our patients. At this point at least in Pakistan,
CEA may be a better option due to local technical expertise.
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